Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SESEN BIO, INC.

(SESN)
  Report
Real-time Estimate Cboe BZX  -  01:16:41 2023-01-27 pm EST
0.6260 USD   +2.02%
01/26Bradley L Radoff Issues a Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support
CI
01/26Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders
BU
01/25Bradley L Radoff Sends a Letter to Sesen Bio Inc
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société SESEN BIO, INC.
01/26Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests o..
BU
01/25Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their App..
BU
01/19Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connecti..
BU
01/05Investor Group Issues Letter to Sesen Bio's Board of Directors Regarding Intent to Vote..
BU
01/04Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
BU
01/03Investor Group Reiterates Intent to Vote AGAINST Sesen Bio's Value-Destructive Merger w..
BU
2022Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Stat..
AQ
2022Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Ca..
BU
2022Sesen Bio : Termination of Material Agreement - Form 8-K
PU
2022Sesen Bio, Inc. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update
BU
2022SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Carisma and Sesen Bio Combine, Raise $30M for CAR-M Therapeutics
AQ
2022Sesen Bio Investor Alert By The Form : Kahn Swick & Foti, LLC Investigates Merger of Sesen..
BU
2022Sesen Bio and Carisma Therapeutics Announce Merger Agreement
BU
2022Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi..
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022Sesen Bio, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2022Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022Sesen Bio : Costs Associated with Exit or Disposal Activities - Form 8-K/A
PU
2022SESEN BIO, INC. Costs Associated with Exit or Disposal Activities (form 8-K/A)
AQ
2022SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2022Sesen Bio Reports Second Quarter 2022 Financial Results and Business Update
BU
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2022Sesen Bio, Inc. : Costs Associated with Exit or Disposal Activities (form 8-K)
AQ
2022Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Termination of a Material De..
AQ
2022Sesen Bio, Inc. : Results of Operations and Financial Condition, Other Events, Financial S..
AQ
2022Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™..
BU
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2022Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2022Sesen Bio Reports First Quarter 2022 Financial Results and Business Update
BU
2022SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2022Sesen Bio Provides Strategic Update
BU
2022Sesen Bio, Inc. : Results of Operations and Financial Condition, Other Events, Financial S..
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2022Sesen Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Anticipated R..
BU
2022Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2022Sesen Bio, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St..
AQ
2022Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2022Sesen Bio Further Enhances Team with Key Hires
BU
2022Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2021Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™
BU
2021Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Sesen Bio Strengthens Medical Team
BU
2021Sesen Bio Director Jane Pritchett Henderson Transitions to CEO Advisor Role
BU
2021Sesen Bio, Inc. : Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
2021Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2021Sesen Bio Reports Third Quarter 2021 Financial Results and Business Update
BU
2021SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result..
AQ
2021Sesen Bio Announces Productive CMC Type A Meeting with the FDA
BU
2021Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2021Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K)
AQ
2021Sesen Bio : Expands CMC and Clinical Teams
BU
2021Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Sesen Bio, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Sesen Bio : Costs Associated with Exit or Disposal Activities (Form 8-K)
PU
2021Sesen Bio, Inc. : Costs Associated with Exit or Disposal Activities (form 8-K)
AQ
2021Sesen Bio, Inc. : Other Events (form 8-K)
AQ
2021Sesen Alert : Bragar Eagel & Squire, P.C. is Investigating Sesen Bio, Inc. on Behalf of Se..
BU
1  2  3  4Next
Upcoming event on SESEN BIO, INC.